Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model

MLA

Johanna J.M. Takkenberg, et al. “Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.” International Journal of Radiation Oncology, Biology, Physics, vol. 93, no. 1, Jan. 2015, pp. 82–90. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2015.05.003.

APA

Johanna J.M. Takkenberg, Suresh Senan, Chandana A. Reddy, Alex P.W.M. Maat, Alexander V. Louie, Frank J. Lagerwaard, Neil M. Woody, Sahar Mokhles, Ben J. Slotman, David A. Palma, Gregory M.M. Videtic, Andrew Warner, Kevin L. Stephans, Cornelis J.A. Haasbeek, & George Rodrigues. (2015). Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model. International Journal of Radiation Oncology, Biology, Physics, 93(1), 82–90. https://doi.org/10.1016/j.ijrobp.2015.05.003

Chicago

Johanna J.M. Takkenberg, Suresh Senan, Chandana A. Reddy, Alex P.W.M. Maat, Alexander V. Louie, Frank J. Lagerwaard, Neil M. Woody, et al. 2015. “Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.” International Journal of Radiation Oncology, Biology, Physics 93 (1): 82–90. doi:10.1016/j.ijrobp.2015.05.003.